|
|
||||||||
: CD8+ Effector Cells Develop Independently of CD4+ Cells and CD40-CD40 Ligand Interactions1


*
Department of Surgery, Section of General Surgery, and Department of Microbiology and Immunology, University of Michigan School of Medicine, Ann Arbor, MI 48109;
Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84132; and
Department of Surgery, Division of Transplantation, Ohio State University School of Medicine, Columbus, OH 43210
Both wild-type (WT) and IFN-
-deficient
(IFN-
-/-) C57BL/6 mice can rapidly reject BALB/c
cardiac allografts. When depleted of CD8+ cells, both WT
and IFN-
-/- mice rejected their allografts, indicating
that these mice share a common CD4-mediated, CD8-independent mechanism
of rejection. However, when depleted of CD4+ cells, WT mice
accepted their allografts, while IFN-
-/- recipients
rapidly rejected them. Hence, IFN-
-/-, but not WT mice
developed an unusual CD8-mediated, CD4-independent, mechanism of
allograft rejection. Allograft rejection in IFN-
-/-
mice was associated with intragraft accumulation of IL-4-producing
cells, polymorphonuclear leukocytes, and eosinophils. Furthermore, this
form of rejection was resistant to treatment with anti-CD40 ligand
(CD40L) mAb, which markedly prolonged graft survival in WT mice. T cell
depletion studies verified that anti-CD40L treatment failed to
prevent CD8-mediated allograft rejection in IFN-
-/-
mice. However, anti-CD40L treatment did prevent CD4-mediated
rejection in IFN-
-/- mice, although grafts were
eventually rejected when CD8+ T cells repopulated the
periphery. The IL-4 production and eosinophil influx into the graft
that occurred during CD8-mediated rejection were apparently
epiphenomenal, since treatment with anti-IL-4 mAb blocked
intragraft accumulation of eosinophils, but did not interfere with
allograft rejection. These studies demonstrate that a novel,
CD8-mediated mechanism of allograft rejection, which is resistant to
experimental immunosuppression, can develop when IFN-
is limiting.
An understanding of this mechanism is confounded by its association
with Th2-like immune events, which contribute unique histopathologic
features to the graft but are apparently unnecessary for the process of
allograft rejection.
This article has been cited by other articles:
![]() |
X. Yuan, M. J. Ansari, F. D'Addio, J. Paez-Cortez, I. Schmitt, M. Donnarumma, O. Boenisch, X. Zhao, J. Popoola, M. R. Clarkson, et al. Targeting Tim-1 to overcome resistance to transplantation tolerance mediated by CD8 T17 cells PNAS, June 30, 2009; 106(26): 10734 - 10739. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yamada, J. Hamuro, A. Fukushima, T. Ohteki, K. Terai, Y. Iwakura, H. Yagita, and S. Kinoshita MHC-Matched Corneal Allograft Rejection in an IFN-{gamma}/IL-17-Independent Manner in C57BL/6 Mice Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2139 - 2146. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Coley, M. L. Ford, S. C. Hanna, M. E. Wagener, A. D. Kirk, and C. P. Larsen IFN-{gamma} Dictates Allograft Fate via Opposing Effects on the Graft and on Recipient CD8 T Cell Responses J. Immunol., January 1, 2009; 182(1): 225 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Burrell, G. Lu, X. C. Li, and D. K. Bishop OX40 Costimulation Prevents Allograft Acceptance Induced by CD40-CD40L Blockade J. Immunol., January 1, 2009; 182(1): 379 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Burrell, K. Csencsits, G. Lu, S. Grabauskiene, and D. K. Bishop CD8+ Th17 Mediate Costimulation Blockade-Resistant Allograft Rejection in T-bet-Deficient Mice J. Immunol., September 15, 2008; 181(6): 3906 - 3914. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhai, Y. Wang, Z. Wu, and J. W. Kupiec-Weglinski Defective Alloreactive CD8 T Cell Function and Memory Response in Allograft Recipients in the Absence of CD4 Help J. Immunol., October 1, 2007; 179(7): 4529 - 4534. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Horne, M. A. Koester, K. Jayashankar, K. E. Lunsford, H. L. Dziema, and G. L. Bumgardner Disparate Primary and Secondary Allospecific CD8+ T Cell Cytolytic Effector Function in the Presence or Absence of Host CD4+ T Cells J. Immunol., July 1, 2007; 179(1): 80 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Nanji, W. W. Hancock, B. Luo, C. D. Schur, R. L. Pawlick, L. F. Zhu, C. C. Anderson, and A.M. J. Shapiro Costimulation Blockade of Both Inducible Costimulator and CD40 Ligand Induces Dominant Tolerance to Islet Allografts and Prevents Spontaneous Autoimmune Diabetes in the NOD Mouse Diabetes, January 1, 2006; 55(1): 27 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Nathan, J. E. Mold, S. C. Wood, K. Csencsits, G. Lu, E. J. Eichwald, and D. K. Bishop Requirement for Donor and Recipient CD40 Expression in Cardiac Allograft Rejection: Induction of Th1 Responses and Influence of Donor-Derived Dendritic Cells J. Immunol., June 1, 2004; 172(11): 6626 - 6633. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Hargrave, C. Hay, J. Mellon, E. Mayhew, and J. Y. Niederkorn Fate of MHC-Matched Corneal Allografts in Th1-Deficient Hosts Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1188 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. He, S. Schenk, Q. Zhang, A. Valujskikh, J. Bayer, R. L. Fairchild, and P. S. Heeger Effects of T Cell Frequency and Graft Size on Transplant Outcome in Mice J. Immunol., January 1, 2004; 172(1): 240 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Beranek, T. El-Sawy, and R. L. Fairchild Unusual Apoptosis in Experimental Cardiac Rejection Am. J. Pathol., December 1, 2003; 163(6): 2640 - 2642. [Full Text] |
||||
![]() |
Y. Matsui, A. Saiura, Y. Sugawara, M. Sata, K. Naruse, H. Yagita, T. Kohro, C. Mataki, A. Izumi, T. Yamaguchi, et al. Identification of gene expression profile in tolerizing murine cardiac allograft by costimulatory blockade Physiol Genomics, November 11, 2003; 15(3): 199 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-W. Zhang, D. D. Kish, and R. L. Fairchild Absence of Allograft ICAM-1 Attenuates Alloantigen-Specific T Cell Priming, But Not Primed T Cell Trafficking into the Graft, to Mediate Acute Rejection J. Immunol., June 1, 2003; 170(11): 5530 - 5537. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miura, T. El-Sawy, and R. L. Fairchild Neutrophils Mediate Parenchymal Tissue Necrosis and Accelerate the Rejection of Complete Major Histocompatibility Complex-Disparate Cardiac Allografts in the Absence of Interferon-{gamma} Am. J. Pathol., February 1, 2003; 162(2): 509 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Nicolls, M. Coulombe, J. Beilke, H. C. Gelhaus, and R. G. Gill CD4-Dependent Generation of Dominant Transplantation Tolerance Induced by Simultaneous Perturbation of CD154 and LFA-1 Pathways J. Immunol., November 1, 2002; 169(9): 4831 - 4839. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Wiseman, B. A. Pietra, B. P. Kelly, G. R. Rayat, M. Rizeq, and R. G. Gill Donor IFN-{gamma} Receptors Are Critical for Acute CD4+ T Cell-Mediated Cardiac Allograft Rejection J. Immunol., November 1, 2001; 167(9): 5457 - 5463. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Halloran, L. W. Miller, J. Urmson, V. Ramassar, L.-F. Zhu, N. M. Kneteman, K. Solez, and M. Afrouzian IFN-{{gamma}} Alters the Pathology of Graft Rejection: Protection from Early Necrosis J. Immunol., June 15, 2001; 166(12): 7072 - 7081. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |